Detalhe da pesquisa
1.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Cancer
; 128(5): 966-974, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784056
2.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.
J Immunother Cancer
; 10(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210307
3.
Novel Alzheimer risk genes determine the microglia response to amyloid-ß but not to TAU pathology.
EMBO Mol Med
; 12(3): e10606, 2020 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31951107
4.
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma.
J Clin Oncol
; 38(33): 3937-3946, 2020 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32997575